Articles tagged with Associate Health Minister

Showing 15 of 18 articles

Pharmac's Progress Report: Improved Patient Voice and Faster Medicine Access 2026

Associate Health Minister David Seymour praises Pharmac’s progress in responding to the 2025/26 Letter of Expectations, highlighting improvements in patient involvement, timeliness of decision-making, and sector collaboration. Key achievements include trialling streamlined assessment pathways, enhancing consumer engagement, updating rare disorder policies, and advancing digital investments, all contributing to a clear multi-year organisational improvement programme. While progress is noted as impressive and transparency has increased, Seymour emphasizes that continued efforts to listen to patients and improve access to medicines remain essential.

Pharmac Enhances Patient Voice with New Community and Patient Advisory Committee

Pharmac is enhancing its engagement with the patient community by establishing a new Community and Patient Advisory Committee (CPAC) to replace existing advisory groups, ensuring patients have a stronger voice in decision-making. This initiative builds on a cultural shift led by new leadership, supported by increased funding and expanded access to medicines benefiting hundreds of thousands of New Zealanders. Recruitment for CPAC members begins in October, with an interim committee guiding its development and implementation ahead of its official launch in the new year.

New Zealand Invests $9M in FASD Community Hubs for Early Diagnosis and Support

New Zealand is investing $9 million to establish its first community-based hubs for Fetal Alcohol Spectrum Disorder (FASD) assessment, diagnosis, and support in Rotorua/Kawerau, Hawke’s Bay, and Gisborne, addressing significant local needs. These hubs aim to provide earlier intervention, comprehensive services, and family support to improve lifelong health, learning, and development outcomes for affected children and young people. This initiative builds on a previous $4.6 million government funding boost to prevent FASD and enhance support, tackling longstanding barriers to timely diagnosis and care.

Pharmac to Widen Rosuvastatin Access for All Based on Clinical Need from 2026

Associate Health Minister David Seymour supports Pharmac’s proposal to remove all eligibility criteria for Rosuvastatin access from October 2026, allowing clinicians to prescribe it based on clinical need regardless of ethnicity. This change aims to improve management of high cholesterol, reduce heart attack and stroke risks, and is expected to increase the number of users by up to 108,000 over five years without affecting current patients. Pharmac will fund this expansion through savings from its 2025/26 Annual Tender, reflecting strong support from health professionals and consumers for timely access to the medicine.

Government Boosts Maternity Care with Longer Postnatal Stays and More Support

The New Zealand Government is investing $34.4 million over four years to increase maternity bed capacity and staff, enabling mothers and babies to have up to a three-day postnatal hospital stay. This funding supports the implementation of the Three Day Postnatal Stay Amendment Bill, which will legally entitle mothers to a minimum three-day stay after childbirth to ensure adequate recovery and bonding time. Health Ministers emphasize that this initiative responds to women’s needs, aiming to improve early postnatal care and outcomes for families and the health system.

New Zealand Boosts Ambulance Services with $35M Investment for Faster Emergency Care

New Zealand's government is investing $35 million over four years, alongside increased funding from Health New Zealand and ACC, to enhance ambulance services by expanding crews, upgrading technology, and improving frontline support. Key initiatives include establishing ambulance hubs in Auckland, deploying electronic patient records, boosting training, and strengthening recruitment and retention of volunteers, particularly in rural areas. This funding aims to meet rising emergency demand, reduce avoidable emergency department transports, and ensure timely, high-quality care for communities nationwide.

Pharmac's Deal with Medtronic to Save $1.2M Annually on Drug-Eluting Stents

Pharmac has proposed a provisional agreement with Medtronic New Zealand to supply 65% of drug-eluting stents to public hospitals, potentially saving $1.2 million annually while ensuring access to high-quality stents. The proposal, developed with input from the Interventional Cardiology Advisory Group, aims to improve procurement efficiency and collaboration between Pharmac and Health New Zealand. Public consultation is open until April 28 to gather feedback from healthcare professionals and stakeholders before finalizing the deal for implementation starting June 2026.

Government Boosts Funding for Smokefree Youth Music Programs to Promote Health

The Government is increasing funding to $550,000 per year for the next three years to support Smokefreerockquest and Smokefree Tangata Beats, youth music programs promoting smokefree and vapefree lifestyles. These events have been instrumental in encouraging creativity and wellbeing among young people for 36 years, contributing to a significant decline in smoking and vaping rates among youth. The 2025 editions achieved record participation and audience engagement, highlighting their effectiveness in reaching and influencing young people.

Pharmac Proposes Funding Trikafta and Alyftrek for All Children with Cystic Fibrosis

Associate Health Minister David Seymour supports Pharmac’s public consultation on funding Trikafta and Alyftrek for children with cystic fibrosis of all ages, aiming to expand access beyond the current age restrictions. If approved, the proposal effective from April 1, 2026, would allow doctors to prescribe these life-changing treatments based on clinical need, addressing early harm caused by cystic fibrosis and improving patient outcomes. Pharmac encourages feedback from patients, families, healthcare professionals, and advocacy groups before the consultation closes on February 11, 2026.

New Zealanders to Benefit from 12-Month Prescriptions and Pharmacist Ownership Changes for Improved Access to Medicines

Starting from February 1, 2026, New Zealanders will have the option to receive 12-month prescriptions for their medications, aiming to save costs and enhance convenience for those on long-term treatments. This change, introduced in Budget 2025, allows stable patients to obtain longer prescriptions, reducing the need for frequent doctor visits and potentially saving up to $105 annually in GP fees. Additionally, the government is removing ownership restrictions for pharmacists to become prescribers, enabling more accessible care and innovation in the healthcare system.

Pharmac Funds Access to New Cancer Treatments, Including Subcutaneous Injections, for Improved Patient Care

Associate Health Minister David Seymour and Health Minister Simeon Brown welcome Pharmac's decision to fund access to five treatments, including for breast and lung cancer, starting from December 1, 2025. Pharmac's decisions include funding new subcutaneous options for existing IV medicines, two new medicines, and ongoing access to certain treatments. The move aims to make patients' lives easier, reduce strain on the health system, and provide better and faster access to cancer care in New Zealand, aligning with the government's focus on improving cancer management and ensuring better access to cancer medicines.

Te Kūiti Hospital Celebrates 100 Years: Rural Healthcare Milestone

Te Kūiti Hospital celebrates its 100-year anniversary, highlighting the crucial role of rural hospitals in providing local healthcare, as emphasized by Health Minister Simeon Brown and Associate Health Minister Matt Doocey. The hospital serves over 14,000 people, offering emergency care, specialist clinics, and allied health support, reducing the need for locals to travel long distances for healthcare. The government is investing in rural healthcare improvements, including $164 million to enhance urgent and after-hours care, with Te Kūiti Hospital being a prototype site for innovative trials shaping rural health services nationwide.

Pharmac's Reset Programme Progress: 90-Day Action Plan Completion and Consumer Engagement

Pharmac's Reset Programme, part of a five-year plan, is progressing well with the completion of the first 90-day action plan, focusing on transparency and accountability in funding decisions for pharmaceuticals. Associate Health Minister David Seymour emphasizes the importance of involving patients, families, and clinicians in decision-making processes to improve the patient-Pharmac relationship. The Consumer and Patient Working Group, chaired by Dr. Malcolm Mulholland, plays a key role in providing insight and practical advice to ensure the programme reflects consumer needs, values, and perspectives, with ongoing plans to enhance patient engagement and communication strategies.

Strengthening Rural Health on the West Coast: Ministers Engage with Greymouth Community

Associate Health Minister Matt Doocey and Minister for Rural Communities Mark Patterson are visiting Greymouth as part of the Rural Health Roadshow to address healthcare challenges in geographically spread-out communities like the West Coast. Budget 2025 allocated $164 million to enhance urgent and after-hours care, aiming to ensure 98% of New Zealanders can reach urgent care within an hour. The Government is dedicated to removing geographic barriers to healthcare access, focusing on strengthening mental health and rural healthcare outcomes for all New Zealanders, especially those in rural communities like Greymouth.

New Zealand’s Emergency Services Boosted by Digital Technology for Rapid Location of At-Risk Individuals

New Zealand's emergency services are implementing the Device Location Information (DLI) service to quickly locate individuals at risk without them having to call 111, enhancing response times in critical situations. The DLI technology allows emergency services to track mobile phones in emergencies, aiding search and rescue operations and assisting in health emergencies by locating individuals who may have fallen unconscious during a call. This new system streamlines the process by eliminating the need for manual requests to mobile network operators, ensuring quicker and more efficient emergency responses while maintaining privacy and transparency through rigorous authorization processes.